NCT00160186View on ClinicalTrials.gov

Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Gastrectomy
Interventions
DRUG

Pancreatin

2 capsules Pancreatin with 25 000 lipase units per main meal (3 meals) and 1 capsule per snack (2-3 snacks)

DRUG

Placebo

Placebo

Trial Locations (9)

Unknown

Site 9, Odense

Site 10, Tampere

Site 1, Bergen

Site 2, Fredrikstad

Site 3, Tromsø

Site 5, Linköping

Site 7, Malmo

Site 6, Stockholm

Site 8, Stockholm

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00160186 - Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy | Biotech Hunter | Biotech Hunter